Fras, J
one BPC-157 (5 mg) vial covers ~10 days at 500 mcg/day
However, although the data obtained from preclinical studies involving a relatively small number of healthy subjects are promising, further comparative trials in larger populations of people with T2DM and obesity are required to confirm the therapeutic potential of this new GLP-1, GIP, and GCG receptor tri-agonist, particularly in comparison with existing selective GLP-1 and dual GLP-1/GIP receptor agonists
Hows your hydration, hows your sleep? If all those things are on point, it could be age or the type of training youre doing. For tendons, platelet-rich-plasma therapy, in which your platelets are concentrated and injected to promote healing, is pricey but proven
Refrigeration is recommended for most products after opening
Everything requires slightly more effort than it should